152 related articles for article (PubMed ID: 37040826)
1. Which trial do we need? Next-generation sequencing to individualize therapy in Staphylococcus aureus bacteraemia.
Mourad A; Fowler VG; Holland TL
Clin Microbiol Infect; 2023 Aug; 29(8):955-958. PubMed ID: 37040826
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin minimum inhibitory concentrations and outcome in patients with severe Staphylococcus aureus infection.
Gould IM
J Infect Dis; 2012 Mar; 205(5):864-5; author reply 865-6. PubMed ID: 22238463
[No Abstract] [Full Text] [Related]
3. Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin.
Hussain A; Kairamkonda V; Jenkins DR
J Med Microbiol; 2011 Mar; 60(Pt 3):381-383. PubMed ID: 21127158
[TBL] [Abstract][Full Text] [Related]
4. Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains.
Moravvej Z; Estaji F; Askari E; Solhjou K; Naderi Nasab M; Saadat S
Int J Antimicrob Agents; 2013 Oct; 42(4):370-1. PubMed ID: 23880172
[No Abstract] [Full Text] [Related]
5. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
Holubar M; Meng L; Alegria W; Deresinski S
Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of vancomycin serum trough concentrations and outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
Arshad S; Shoyinka A; Chen A; Jacobsen G; Zervos M
Int J Antimicrob Agents; 2012 Nov; 40(5):474-5. PubMed ID: 22883416
[No Abstract] [Full Text] [Related]
7. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin.
Nace H; Lorber B
J Antimicrob Chemother; 2010 Jun; 65(6):1315-6. PubMed ID: 20375035
[No Abstract] [Full Text] [Related]
8. Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature.
Polenakovik HM; Pleiman CM
Int J Antimicrob Agents; 2013 Nov; 42(5):450-5. PubMed ID: 23993067
[TBL] [Abstract][Full Text] [Related]
9. Methicillin-resistant Staphylococcus aureus bacteremia and pneumonia.
Ganesan A
Dis Mon; 2008 Dec; 54(12):787-92. PubMed ID: 18996281
[No Abstract] [Full Text] [Related]
10. Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia.
McCalla C; Smyth DS; Robinson DA; Steenbergen J; Luperchio SA; Moise PA; Fowler VG; Sakoulas G
Antimicrob Agents Chemother; 2008 Sep; 52(9):3441-3. PubMed ID: 18606839
[TBL] [Abstract][Full Text] [Related]
11. [Methicillin-susceptible Staphylococcus aureus bacteraemia].
Gueissaz L; Hauri N; Kocher J; Lavallée MA; Munday MF; Renggli L; Béguelin C
Rev Med Suisse; 2022 Oct; 18(799):1889-1895. PubMed ID: 36226450
[TBL] [Abstract][Full Text] [Related]
12. Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged.
Barry A; McNicholas S; Smyth E; Humphreys H; Fitzpatrick F
J Hosp Infect; 2010 Nov; 76(3):272-3. PubMed ID: 20435374
[No Abstract] [Full Text] [Related]
13. Influence of early daptomycin therapy on treatment outcome of meticillin-resistant Staphylococcus aureus bacteraemia with high vancomycin minimum inhibitory concentrations.
Cheng CW; Hsu PC; Yang CC; Chang HJ; Siu LK; Wu TL; Huang CT; Lee MH
Int J Antimicrob Agents; 2013 Mar; 41(3):293-4. PubMed ID: 23312599
[No Abstract] [Full Text] [Related]
14. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R
Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462
[TBL] [Abstract][Full Text] [Related]
15. Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia.
Lewis PO; Heil EL; Covert KL; Cluck DB
J Clin Pharm Ther; 2018 Oct; 43(5):614-625. PubMed ID: 30003555
[TBL] [Abstract][Full Text] [Related]
16. Eligibility of patients with Staphylococcus aureus bacteraemia for early oral switch.
Cooper G; Dolby HW; Berry K; Russell CD
Lancet Infect Dis; 2024 Apr; 24(4):e209-e210. PubMed ID: 38309279
[No Abstract] [Full Text] [Related]
17. The detection and clinical impact of vancomycin MIC among patients with methicillin-resistant Staphylococcus aureus bacteremia.
Huang CH; Chen YH
J Microbiol Immunol Infect; 2013 Aug; 46(4):315-6. PubMed ID: 23623179
[No Abstract] [Full Text] [Related]
18. Clinical predictors of methicillin-resistance and their impact on mortality associated with Staphylococcus aureus bacteraemia.
Wi YM; Rhee JY; Kang CI; Chung DR; Song JH; Peck KR
Epidemiol Infect; 2018 Jul; 146(10):1326-1336. PubMed ID: 29781425
[TBL] [Abstract][Full Text] [Related]
19. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
[TBL] [Abstract][Full Text] [Related]
20. Successful management of methicillin-resistant Staphylococcus aureus bacteremia complicated with diffuse myelitis.
Eduwu J; Tabasam F; Bastidas AA; Dar K; Ahmed Y
Infect Dis (Lond); 2017 Mar; 49(3):234-236. PubMed ID: 27464005
[No Abstract] [Full Text] [Related]
[Next] [New Search]
